CLINICAL_TRIALS
research
· 2020-02-11
Clinical Trial Update: Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife) [Phase 4]
Summary
Phase 4 trial update focusing on patient-reported GI and health-related quality of life outcomes in renal transplant recipients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis | Conditions: Renal Transplantation, Gastrointestinal Problems | Phase 4 | Status: COMPLETED